214 related articles for article (PubMed ID: 19472790)
1. [Rituximab: a new therapeutic arm in refractory rheumatoid arthritis: about one case].
Abdelmoula LC; Testouri N; Ben Hadj Yahia C; Tekaya R; Ben M'barek R; Chaabouni L; Zouari R
Tunis Med; 2008 Sep; 86(9):841-2. PubMed ID: 19472790
[No Abstract] [Full Text] [Related]
2. Costs of rituximab maintenance treatment in patients with refractory rheumatoid arthritis.
Risselada A; Tekstra J; Teng YK; Welsing PM; Breedveld F; van Laar JM; Bijlsma JW
Ann Rheum Dis; 2010 Oct; 69(10):1891-2. PubMed ID: 20444758
[No Abstract] [Full Text] [Related]
3. A single course of rituximab does not abrogate anti-infliximab antibodies in patients with rheumatoid arthritis.
van den Bemt BJ; Vos K; den Broeder AA; Blom M; Thurlings RM; Bartelds GM; Stapel SO; Barrera P; Tak PP; Nurmohamed MT; Wolbink GJ
Ann Rheum Dis; 2009 Aug; 68(8):1368-9. PubMed ID: 19605744
[No Abstract] [Full Text] [Related]
4. [Rituximab (Mabthera)--new approach in treatment of rheumatoid arthritis].
Anić B
Reumatizam; 2007; 54(2):72-3. PubMed ID: 18351146
[No Abstract] [Full Text] [Related]
5. Successful treatment of rheumatoid vasculitis-associated cutaneous ulcers using rituximab in two patients with rheumatoid arthritis.
Hellmann M; Jung N; Owczarczyk K; Hallek M; Rubbert A
Rheumatology (Oxford); 2008 Jun; 47(6):929-30. PubMed ID: 18411212
[No Abstract] [Full Text] [Related]
6. Severe refractory rheumatoid arthritis successfully treated with combination rituximab and anti-tumor necrosis factor-alpha-blocking agents.
Koumakis E; Wipff J; Avouac J; Kahan A; Allanore Y
J Rheumatol; 2009 Sep; 36(9):2125-6. PubMed ID: 19738227
[No Abstract] [Full Text] [Related]
7. Rituximab in rheumatoid arthritis following anti-TNF-associated tuberculosis.
Burr ML; Malaviya AP; Gaston JH; Carmichael AJ; Ostör AJ
Rheumatology (Oxford); 2008 May; 47(5):738-9. PubMed ID: 18375402
[No Abstract] [Full Text] [Related]
8. Rituximab fixed retreatment versus on-demand retreatment in refractory rheumatoid arthritis: comparison of two B cell depleting treatment strategies.
Teng YK; Tekstra J; Breedveld FC; Lafeber F; Bijlsma JW; van Laar JM
Ann Rheum Dis; 2009 Jun; 68(6):1075-7. PubMed ID: 19435725
[No Abstract] [Full Text] [Related]
9. Safety of combination therapy with rituximab and etanercept for patients with rheumatoid arthritis.
Blank N; Max R; Schiller M; Briem S; Lorenz HM
Rheumatology (Oxford); 2009 Apr; 48(4):440-1. PubMed ID: 19153143
[No Abstract] [Full Text] [Related]
10. Membranous glomerulopathy associated with rheumatoid arthritis may respond to rituximab.
Pixley J; Wolf B; O'Neill W
Scand J Rheumatol; 2008; 37(4):313-4. PubMed ID: 18612934
[No Abstract] [Full Text] [Related]
11. [Administration of rituximab in rheumatoid arthritis from the position of evidence-based medicine].
Nasonov EL
Ter Arkh; 2007; 79(12):76-82. PubMed ID: 18220039
[No Abstract] [Full Text] [Related]
12. Rituximab (Rituxan) for rheumatoid arthritis.
Med Lett Drugs Ther; 2006 Apr; 48(1233):34-5. PubMed ID: 16625143
[No Abstract] [Full Text] [Related]
13. Rituximab for treatment of scleritis associated with rheumatoid arthritis.
Chauhan S; Kamal A; Thompson RN; Estrach C; Moots RJ
Br J Ophthalmol; 2009 Jul; 93(7):984-5. PubMed ID: 19553514
[No Abstract] [Full Text] [Related]
14. Efficacy and safety of rituximab in a patient with active rheumatoid arthritis and chronic disseminated pulmonary aspergillosis and history of tuberculosis.
Jung N; Owczarczyk K; Hellmann M; Lehmann C; Fätkenheuer G; Hallek M; Rubbert A
Rheumatology (Oxford); 2008 Jun; 47(6):932-3. PubMed ID: 18417524
[No Abstract] [Full Text] [Related]
15. Use of rituximab for the treatment of rheumatoid arthritis: the Latin American context.
Soriano ER; Galarza-Maldonado C; Cardiel MH; Pons-Estel BA; Massardo L; Caballero-Uribe CV; Achurra-Castillo AF; Barile-Fabris LA; Chávez-Corrales J; Díaz-Coto JF; Esteva-Spinetti MH; Guibert-Toledano M; Palazuelos FI; Keiserman MW; Lomonte AV; Mota LM; Pineda Villaseñor C; Alarcón GS;
Rheumatology (Oxford); 2008 Jul; 47(7):1097-9. PubMed ID: 18463144
[No Abstract] [Full Text] [Related]
16. Successful treatment of rheumatoid vasculitis-associated foot drop with rituximab.
Maher LV; Wilson JG
Rheumatology (Oxford); 2006 Nov; 45(11):1450-1. PubMed ID: 16936329
[No Abstract] [Full Text] [Related]
17. Long term treatment of rheumatoid arthritis with rituximab.
Caporali R; Caprioli M; Bobbio-Pallavicini F; Bugatti S; Montecucco C
Autoimmun Rev; 2009 Jun; 8(7):591-4. PubMed ID: 19393205
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome and B cell depletion in patients with rheumatoid arthritis receiving rituximab monotherapy in comparison with patients receiving concomitant methotrexate.
Owczarczyk K; Hellmann M; Fliedner G; Röhrs T; Maizus K; Passon D; Hallek M; Rubbert A
Ann Rheum Dis; 2008 Nov; 67(11):1648-9. PubMed ID: 18854518
[No Abstract] [Full Text] [Related]
19. Rituximab and abatacept for rheumatoid arthritis.
BMJ Group
Drug Ther Bull; 2008 Aug; 46(8):57-61. PubMed ID: 18687584
[TBL] [Abstract][Full Text] [Related]
20. B cell depletion in early rheumatoid arthritis: a new concept in therapeutics.
Renato GM
Ann N Y Acad Sci; 2009 Sep; 1173():729-35. PubMed ID: 19758222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
